In this study, we aimed to determine (1) whether assessments of TIMP-1 gene copy number in the tumor cells and/or (2) measurement of plasma TIMP-1 protein levels could substitute TIMP-1 immunohistochemistry in glioma research. Here, TIMP1 is linked to glioma.